In this study, we used ephrinA1 fusion protein and verified that ephrinA1 can activate EphA1 but not EphA2 receptors in an EphA1-negative HCC cell line of HLE cells (Additional file 2: Figure S2), which was similar to Iida’s findings [16]. The gene discussed is EPHA1; the disease is hepatocellular carcinoma.